Concepedia

Christophe Hotermans

CH

19

Publications

2.4K

Citations

15

H-Index

2006

Active since

Affiliations

Biogen (United States)(Current)

University Hospital of Basel

University of Liège

Cleveland Clinic

University of Münster

Christophe Hotermans is an author at Biogen (United States) specializing in medicine, pharmacotherapy, and clinical trials.

Top concepts

Publications per year

2006–2022

19

Publications

19

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

Gary Bloomgren, Sandra Richman, Christophe Hotermans et al. · New England Journal of Medicine · 2012 · 1.2K citations · Full text

Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing

Lana Zhovtis Ryerson, John Foley, Ih Chang et al. · Neurology · 2019 · 186 citations · Full text

Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results

Helmut Butzkueven, Ludwig Kappos, Fabio Pellegrini et al. · Journal of Neurology Neurosurgery & Psychiatry · 2014 · 171 citations · Full text

Early boost and slow consolidation in motor skill learning

Christophe Hotermans, Philippe Peigneux, Alain Maertens de Noordhout et al. · Learning & Memory · 2006 · 118 citations · Full text

, , +17

Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome

Darin T. Okuda, Orhun H. Kantarci, Christine Lebrun‐Frénay et al. · Annals of Neurology · 2022 · 113 citations

Rows per page

1–5 of 19